In situ extension as an approach for identifying novel alpha-amylase inhibitors
The structure was published by Numao, S., Damager, I., Li, C., et al., Overall, C.M., Brayer, G.D., and Withers, S.G., in 2004 in a paper entitled "In Situ Extension as an Approach for Identifying Novel alpha-Amylase Inhibitors." (abstract).
This crystal structure was determined using X-ray diffraction at a resolution of 1.95 Å and deposited in 2004.
The experimental data on which the structure is based was also deposited.
The PDB entry contains the structure of Alpha-amylase, pancreatic. This molecule has the UniProt identifier P04746 (AMYP_HUMAN). The sample contained 496 residues which is 100% of the natural sequence. Out of 496 residues 495 were observed and are deposited in the PDB.
It also contains one or more heterogenic compounds (e.g., ligands, co-factors, ions, modified amino acids, etc.); see here for a complete list.
The molecule is most likely monomeric.
The following tables show cross-reference information to other databases (to obtain a list of all PDB entries sharing the same property or classification, click on the magnifying glass icon):
This entry contains 1 unique UniProt protein: